Hosted on MSN11mon
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine
In data announced at the ongoing Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024 in Lisbon, Portugal, participants receiving UB-312 demonstrated a 20% reduction in ...
Hosted on MSN11mon
Annovis Bio to Shed Light on Neurodegenerative Diseases at International Conference
MALVERN, PA — Chester County-based Annovis Bio, Inc. (NYSE: ANVS) is set to make a significant impact at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024 ...
The New England Journal of Medicine7mon
Aromatic Amino Acids and Modification of Parkinsonism
Seventeen patients with Parkinsonism were admitted to this study. All had been referred to us by their physicians, after treatment with several standard medications for relief of this disorder ...